OncoResponse Revenue and Competitors

Claim your profile

Seattle, WA USA

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • OncoResponse's estimated annual revenue is currently $2.9M per year.(i)
  • OncoResponse's estimated revenue per employee is $81,600

Employee Data

  • OncoResponse has 36 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.1M2N/AN/AN/A
#2
$0.3M5N/AN/AN/A
#3
$741.1M51908%N/AN/A
#4
$1.6M23N/AN/AN/A
#5
$2.5M31-42%N/AN/A
#6
$3.8M46-39%N/AN/A
#7
$2.9M36N/AN/AN/A
#8
$1.5M21-19%N/AN/A
#9
$0.9M15N/AN/AN/A
#10
$5.8M63-2%N/AN/A

OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer. Through our partnership with MD Anderson Cancer Center, we deploy a unique and transformative approach to the discovery of cancer therapeutics. OncoResponse is based in Seattle, Washington.

keywords:N/A

N/A

Total Funding

36

Number of Employees

$2.9M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

OncoResponse News

2022-03-22 - OncoResponse Announces Oral Presentation at Festival of ...

OncoResponse is a clinical-stage, immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11M36N/AN/A
#2
$5.2M36N/AN/A
#3
$7M369%N/A
#4
$4.2M36N/AN/A
#5
N/A36N/AN/A